Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03848689Completed
FQ Restriction for the Prevention of CDI
C Difficile ColitisClostridium DifficileClostridium Difficile Infection
PrincipalinvestigatorStart date: 2019-05-01
NCT03462459Phase 2Completed
Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection
C. Diff ColitisC.Difficile ColitisC.Difficile Diarrhea+3 more
PrincipalinvestigatorStart date: 2018-05-21

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

CDIClostridioides difficileClostridium difficile Infections
Similarity Score11%

Darrell Pardi, MD

Mayo Clinic

Related
3 trials

Shared therapeutic areas:

CDIClostridioides difficileClostridium difficile Infections

Worked with same sponsors:

Mayo Clinic
Similarity Score11%

Dina Kao, MD

University of Alberta

Related
8 trials

Shared therapeutic areas:

Clostridioides difficileRecurrent Clostridium Difficile Infection
Similarity Score8%

Patrice Allibert

Meridian Bioscience, Inc.

Related
3 trials

Shared therapeutic areas:

Clostridium difficile Infections
Similarity Score4%

Judit Szabo, M.D., Ph.D.

University of Debrecen

Related
1 trials

Shared therapeutic areas:

Clostridium difficile Infections
Similarity Score4%

Eva Rakoczi, M.D.

Kenezy Gyula Korhaz es Rendelointezet

Related
1 trials

Shared therapeutic areas:

Clostridium difficile Infections
Similarity Score4%

Evangelos J Giamarellos-Bourboulis, MD, Phd

Hellenic Sepsis Study Group

Related
3 trials

Shared therapeutic areas:

Clostridium difficile Infections
Similarity Score4%

Istvan Varkonyi, M.D.

Kenezy Gyula Korhaz es Rendelointezet

Related
1 trials

Shared therapeutic areas:

Clostridium difficile Infections
Similarity Score4%

Tibor Pap, M.D.

Miskolci Semmelweis Korhaz es Egyetemi Oktatokorhaz

Related
1 trials

Shared therapeutic areas:

Clostridium difficile Infections
Similarity Score4%

Purna Kashyap, MD

Mayo Clinic

Related
3 trials

Shared therapeutic areas:

Clostridium difficile Infections

Worked with same sponsors:

Mayo Clinic
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03848689PrincipalInvestigator

FQ Restriction for the Prevention of CDI

C Difficile ColitisClostridium DifficileClostridium Difficile Infection
Completed
NCT03462459Phase 2PrincipalInvestigator

Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection

C. Diff ColitisC.Difficile ColitisC.Difficile Diarrhea+3 more
Completed

All 2 trials loaded